Nuvation Bio Inc.
US ˙ NYSE ˙ US67080N1019

SecurityNUVB / Nuvation Bio Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership2,052,691 shares
Latest Disclosed Value $ 8,806,044
Dimensional Fund Advisors Lp reports 0.66% decrease in ownership of NUVB / Nuvation Bio Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 2,052,691 shares of Nuvation Bio Inc. (US:NUVB) valued at $8,806,044 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,066,360 shares of Nuvation Bio Inc.. This represents a change in shares of -0.66% during the quarter. The current value of the position is $9,688,702 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NUVATION BIO COM CL A 67080N101 2,052,691 -13,669 -0.66 8,806 -52.44 0.0004
2026-02-12 2025-12-31 13F NUVATION BIO COM CL A 67080N101 2,066,360 -1,254,889 -37.78 18,515 50.83 0.0039
2025-11-12 2025-09-30 13F NUVATION BIO COM CL A 67080N101 3,321,249 551,508 19.91 12,276 127.31 0.0026
2025-08-12 2025-06-30 13F NUVATION BIO COM CL A 67080N101 2,769,741 276,859 11.11 5,401 23.06 0.0013
2025-05-13 2025-03-31 13F NUVATION BIO COM CL A 67080N101 2,492,882 1,265,730 103.14 4,389 34.44 0.0011
2025-02-13 2024-12-31 13F NUVATION BIO COM CL A 67080N101 1,227,152 -432,720 -26.07 3,264 -14.13 0.0008
2024-11-07 2024-09-30 13F NUVATION BIO COM CL A 67080N101 1,659,872 641,543 63.00 3,802 27.81 0.0009
2024-08-09 2024-06-30 13F NUVATION BIO COM CL A 67080N101 1,018,329 820,669 415.19 2,975 313.63 0.0008
2024-05-10 2024-03-31 13F NUVATION BIO COM CL A 67080N101 197,660 155,422 367.97 719 1,041.27 0.0002
2024-02-07 2023-12-31 13F NUVATION BIO COM CL A 67080N101 42,238 0 0.00 64 12.50 0.0000
2023-11-09 2023-09-30 13F NUVATION BIO COM CL A 67080N101 42,238 3,981 10.41 57 -17.65 0.0000
2023-08-09 2023-06-30 13F NUVATION BIO COM CL A 67080N101 38,257 -225,486 -85.49 69 -84.44 0.0000
2023-05-12 2023-03-31 13F NUVATION BIO COM CL A 67080N101 263,743 -39,125 -12.92 438 0.0001
2023-02-09 2022-12-31 13F NUVATION BIO COM CL A 67080N101 302,868 -6,810 -2.20 1 -100.00 0.0002
2022-11-10 2022-09-30 13F NUVATION BIO COM CL A 67080N101 309,678 255,995 476.86 694 298.85 0.0003
2022-08-12 2022-06-30 13F NUVATION BIO COM CL A 67080N101 53,683 53,683 174 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.